A carregar...

Pravastatin Therapy and Biomarker Changes in Children and Young Adults with Autosomal Dominant Polycystic Kidney Disease

BACKGROUND AND OBJECTIVES: Disease-specific treatment options for autosomal dominant polycystic kidney disease are limited. Clinical intervention early in life is likely to have the greatest effect. In a 3-year randomized double-blind placebo-controlled phase 3 clinical trial, the authors recently s...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin J Am Soc Nephrol
Main Authors: Klawitter, Jelena, McFann, Kim, Pennington, Alexander T., Wang, Wei, Klawitter, Jost, Christians, Uwe, Schrier, Robert W., Gitomer, Berenice, Cadnapaphornchai, Melissa A.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Nephrology 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4559520/
https://ncbi.nlm.nih.gov/pubmed/26224879
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.11331114
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!